Renaissance Technologies
DRTS icon

Renaissance Technologies’s Alpha Tau Medical DRTS Stock Holding History

Renaissance Technologies’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-40,457
Closed -$286K – 3293
2026
Q1 		$286K Buy
+40,457
New +$286K ﹤0.01% 2805
2025
Q4 		– Sell
-61,900
Closed -$279K – 3359
2025
Q3 		$279K Buy
61,900
+32,500
+111% +$111K ﹤0.01% 3027
2025
Q2 		$91.7K Buy
+29,400
New +$82.8K ﹤0.01% 3313
2025
Q1 		– Sell
-41,000
Closed -$127K – 3542
2024
Q4 		$127K Buy
41,000
+26,800
+189% +$68.6K ﹤0.01% 3249
2024
Q3 		$33.8K Buy
+14,200
New +$31.4K ﹤0.01% 3386
2024
Q2 		– Sell
-14,700
Closed -$43K – 3588
2024
Q1 		$43K Sell
14,700
-9,900
-40% -$30.4K ﹤0.01% 3505
2023
Q4 		$74K Buy
+24,600
New +$79.2K ﹤0.01% 3376
2022
Q4 		– Sell
-19,016
Closed -$111K – 4166
2022
Q3 		$111K Buy
+19,016
New +$168K ﹤0.01% 3558

Other funds holding DRTS

GIA
Gem Investment Advisors Teaneck, New Jersey $163M AUM
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Renaissance Technologies's DRTS Position: Q2 2026 in Review

Renaissance Technologies sold out of Alpha Tau Medical (DRTS) in Q2 2026, closing a stake of 40,457 shares — an estimated $286K sold.

Renaissance Technologies first reported a position in DRTS in Q3 2022 and held it in 8 quarters. The position peaked at $286K in Q1 2026. 74 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.

  • Renaissance Technologies reported no remaining Alpha Tau Medical position as of Q2 2026 after selling out during the quarter.
  • Renaissance Technologies sold 40,457 Alpha Tau Medical shares in Q2 2026, an estimated $286K.
  • Renaissance Technologies first reported a position in Alpha Tau Medical in Q3 2022 and held it in 8 quarters.
  • Renaissance Technologies's Alpha Tau Medical position peaked at $286K in Q1 2026.
  • 74 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.